HOOKIPA PHARMA INC's ticker is HOOK and the CUSIP is 43906K100. A total of 44 filers reported holding HOOKIPA PHARMA INC in Q3 2023. The put-call ratio across all filers is 0.18 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $377 | +45.6% | 612 | +108.2% | 0.00% | – |
| Q2 2023 | $259 | +24.5% | 294 | +4.3% | 0.00% | – |
| Q1 2023 | $208 | -79.8% | 282 | -77.9% | 0.00% | – |
| Q4 2022 | $1,032 | +3.2% | 1,274 | +39.5% | 0.00% | – |
| Q3 2022 | $1,000 | 0.0% | 913 | -2.1% | 0.00% | – |
| Q2 2022 | $1,000 | -99.0% | 933 | -98.0% | 0.00% | – |
| Q1 2022 | $104,000 | -11.1% | 45,656 | -9.0% | 0.00% | – |
| Q4 2021 | $117,000 | -85.4% | 50,171 | -63.1% | 0.00% | – |
| Q3 2021 | $800,000 | +34.0% | 135,873 | +108.2% | 0.00% | – |
| Q2 2021 | $597,000 | +176.4% | 65,257 | +306.9% | 0.00% | – |
| Q1 2021 | $216,000 | -20.3% | 16,036 | -34.4% | 0.00% | – |
| Q4 2020 | $271,000 | +18.9% | 24,459 | +1.0% | 0.00% | – |
| Q3 2020 | $228,000 | -21.6% | 24,211 | -3.3% | 0.00% | – |
| Q2 2020 | $291,000 | +419.6% | 25,031 | +268.4% | 0.00% | – |
| Q1 2020 | $56,000 | +366.7% | 6,795 | +626.7% | 0.00% | – |
| Q4 2019 | $12,000 | +500.0% | 935 | +281.6% | 0.00% | – |
| Q3 2019 | $2,000 | – | 245 | +965.2% | 0.00% | – |
| Q2 2019 | $0 | – | 23 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Redmile Group, LLC | 1,842,902 | $17,452,000 | 0.32% |
| Samsara BioCapital, LLC | 116,602 | $1,104,000 | 0.31% |
| Artal Group S.A. | 599,616 | $5,678,000 | 0.14% |
| HHLR ADVISORS, LTD. | 943,254 | $8,933,000 | 0.07% |
| DAFNA Capital Management LLC | 22,061 | $209,000 | 0.07% |
| Baker Brothers Advisors | 700,481 | $6,634,000 | 0.03% |
| ZACKS INVESTMENT MANAGEMENT | 72,064 | $682,000 | 0.01% |
| HOWLAND CAPITAL MANAGEMENT LLC | 14,728 | $139,000 | 0.01% |
| ETF MANAGERS GROUP, LLC | 14,374 | $139,000 | 0.00% |
| Squarepoint Ops LLC | 12,699 | $120,000 | 0.00% |